PHILADELPHIA (CBS) — A young woman from Montgomery County is fighting desperately for her life: She needs a lung transplant but most hospitals are turning her down. Following tubing to …
Rejection
-
Lung Transplantation
-
Kidney Transplantation
HI-Bio Announces Positive Results from Phase 2 Study of Felzalutamab for Late Antibody-Mediated Rejection in Kidney Transplant Patients
by HI-Bioby HI-Bio82% (n=9/11) of patients who received felzaltamab experienced resolution of symptoms. Antibody-mediated rejection The proportion of patients meeting the Banff criteria in the 24-week biopsy was significantly increased compared to …
-
Ankit Bharat, MBBS, the Harold L. and Margaret N. Methods Professor of Surgery and chief of the Department of Thoracic Surgery, is co-author of the study published in the Journal …
-
Lung Transplantation
TFF Pharmaceuticals Announces Interim Data from a Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) to Prevent Lung Transplant Rejection at the 44th International Society for Heart and Lung Transplantation (ISHLT) 2024 Annual Meeting
TFF Pharma Co., Ltd. Oral Presentation Presenting Latest Data from a Phase 2 Study Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TAC FORT WORTH, Texas, March 25, …
-
News
Eledon Pharmaceuticals Announces Enrollment of 12th Participant in Phase 2 BESTOW Study Evaluating Tegopulvert for Prevention of Organ Rejection
Eredon Pharmaceuticals Co., Ltd. IRVINE, Calif., March 25, 2024 (Globe Newswire) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the registration of 12 pharmaceutical companies.th On March 23, 2024, …